Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations

scientific article published in August 1997

Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/JN.1997.78.2.582
P698PubMed publication ID9307096

P2093author name stringL Zhang
M Oz
R W Peoples
F F Weight
J Harvey-White
U Brauneis
P2860cites workFunctional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAsQ28508730
Cloning and expression of a glycine transporter reveal colocalization with NMDA receptorsQ28565322
Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytesQ34048105
Evidence for a Selective Processing of Proenkephalin B into Different Opioid Peptide Forms in Particular Regions of Rat Brain and PituitaryQ34247866
Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursorQ34707265
Activity-dependent neuronal plasticity following tissue injury and inflammationQ35315392
Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptideQ36380726
Metabolism of dynorphin A 1-13 in human blood and plasma.Q36672007
Differential biotransformation of dynorphin A (1-17) and dynorphin A (1-13) peptides in human blood, ex vivoQ36830480
Cloning, expression, and localization of a rat brain high-affinity glycine transporterQ37139339
Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicityQ37602347
Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical studyQ37603499
Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampusQ37691150
Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicityQ41089451
Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effectsQ41173738
Dynorphin A: in vivo release in the spinal cord of the cat.Q42475128
Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-ProQ44332718
The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat.Q44332997
Focal stimulation of the mossy fibers releases endogenous dynorphins that bind kappa 1-opioid receptors in guinea pig hippocampusQ44335147
The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiationQ44337992
Multiple opioid peptides and the modulation of pain: immunohistochemical analysis of dynorphin and enkephalin in the trigeminal nucleus caudalis and spinal cord of the cat.Q44345405
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid ReceptorQ44352111
The Hypothalamic Paraventricular Nucleus: Relationship to Brain and Pituitary Pools of Vasopressin and Oxytocin as Compared to Dynorphin, β-Endorphin and Related Opioid Peptides in the RatQ44352418
A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate siteQ45816731
Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neuronsQ48435220
Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.Q48535995
Nonopiate effects of dynorphin and des-Tyr-dynorphinQ48860062
Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptorQ48874861
cellular responses to electrophoretically applied dynorphin in the rat hippocampusQ48883563
PITC derivatives in amino acid analysisQ59060192
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectdynorphinQ324076
P304page(s)582-590
P577publication date1997-08-01
P1433published inJournal of NeurophysiologyQ1709863
P1476titlePotentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations
P478volume78

Reverse relations

cites work (P2860)
Q3048145030 years of dynorphins--new insights on their functions in neuropsychiatric diseases
Q41835336A non-opioid pathway for dynorphin-caused spinal cord injury in rats
Q30491472Bi-phasic intensity-dependent opioid-mediated neural amplitude changes in the chinchilla cochlea: partial blockade by an N-Methyl-D-Aspartate (NMDA)-receptor antagonist
Q77223749Calcitonin gene-related peptide rapidly downregulates nicotinic receptor function and slowly raises intracellular Ca2+ in rat chromaffin cells in vitro
Q36798771Constitutive activation of the N-methyl-D-aspartate receptor via cleft-spanning disulfide bonds
Q36776735Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors
Q27863344Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity
Q41910089Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons
Q40609104Dynorphin A inhibits NMDA receptors through a pH-dependent mechanism
Q44349246Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons
Q43070514Endogenous opiates: 1997.
Q43680252Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development
Q28290774Glutamate receptor ion channels: structure, regulation, and function
Q41859431Kappa opioid receptor antagonist and N-methyl-D-aspartate receptor antagonist affect dynorphin-induced spinal cord electrophysiologic impairment
Q42469311Kir6.2 oligoantisense administered into the globus pallidus reduces apomorphine-induced turning in 6-OHDA hemiparkinsonian rats
Q48158372Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum
Q33989361NMDA receptors in the basal ganglia
Q35570829New advances in NMDA receptor pharmacology
Q35007416Pathobiology of dynorphins in trauma and disease
Q47380045Persistent inflammatory nociception increases levels of dynorphin1-17 in the spinal cord, but not in supraspinal nuclei involved in pain modulation
Q37152269Pronociceptive actions of dynorphin via bradykinin receptors
Q36992406The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective
Q48284194The induction of pain: an integrative review

Search more.